TickerFacts.

Zhengye Biotechnology Holding Ltd (ZYBT): Operating Income

Annual figures by period end, from SEC filings.

-70.51M CNY
Year ended 2025-12-31
65.83M CNY2022-12-31: 65.83M CNY2023-12-31: 44.99M CNY2024-12-31: 16.44M CNY2025-12-31: -70.51M CNY-70.51M CNY
2022-12-31 Operating Income (CNY) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-70.51M CNYn/m2026-04-28, From 2025-01-01
2024-12-3116.44M CNY-63.5%2026-04-28, From 2024-01-01
2023-12-3144.99M CNY-31.7%2026-04-28, From 2023-01-01
2022-12-3165.83M CNYn/a2025-07-03, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-31-70.51M CNYn/m
Yatsen Holding Ltd (YSG)2025-12-31-185.79M CNYn/m

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗